JNHMF (Jack Nathan Medical) Research & Development: $0.06 Mil (TTM As of Oct. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Jack Nathan Medical Research & Development?

Jack Nathan Medical JNHMF -90.42% Research & Development is $0.06 Mil as of Oct. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. Jack Nathan Medical's Research & Development for the three months ended in Oct. 2023 was $0.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2023 was $0.06 Mil.

Jack Nathan Medical  (OTCPK:JNHMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Jack Nathan Medical Research & Development Related Terms

Jack Nathan Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Jack Nathan Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jack Nathan Medical Research & Development Chart

Jack Nathan Medical Annual Data
Trend Dec18 Dec19 Jan20 Jan21 Jan22 Jan23
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.08 0.43 0.18

Jack Nathan Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.02 0.00 0.02 0.02

Jack Nathan Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.06 Mil mean?
Jack Nathan Medical (JNHMF) has a Research & Development of $0.06 Mil as of Oct. 2023. Research and development expense is the total cost for research and development activities. View historical data on Jack Nathan Medical and its competitors.
Is Jack Nathan Medical's Research & Development too high?
Jack Nathan Medical's current Research & Development is $0.06 Mil.
How does Jack Nathan Medical's Research & Development compare to HCA and UHS?
Jack Nathan Medical's Research & Development of $0.06 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Jack Nathan Medical and its competitors. Jack Nathan Medical's current Research & Development is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jack Nathan Medical stock overvalued right now?
Jack Nathan Medical (JNHMF) has a current Research & Development of $0.06 Mil. The current Research & Development is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Jack Nathan Medical (JNHMF), the current Research & Development is $0.06 Mil as of Oct. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jack Nathan Medical Business Description

Address 6 - 6150 Highway 7, Suite 491, Jack Nathan Health, Woodbridge, ON, CAN, L4H 0R6
Jack Nathan Medical Corp is a provider of primary care medical clinics located in Walmart Supercentres under the Jack Nathan Health brand. The company designs, builds and sets barrier-free medical clinics for physicians in high-density centers, providing patients with an opportunity to receive immediate access to quality care in modern facilities.